Cell-based therapies are an exciting area across the board in oncology. Here, our experts discuss the use of cellular therapy for viral lymphomas, in a discussion chaired by Catherine Bollard, MBChB, MD, FRACP, FRCPA, of the Children’s National Health System, Washington, DC. Joining the discussion are Ruth Jarrett, MD, PhD, from the University of Glasgow Center for Virus Research, Glasgow, UK, Mark Roschewski, MD, of the National Cancer Institute, Bethesda, MD, and Richard Little, MD, of the National Cancer Institute, Rockville, MD. The need for improved drug access in developing countries is highlighted by the experts, as well as the need to therapeutically target EBNA1. This video was recorded at the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting, held in Nice, France.
Cellular therapy and drug access for viral lymphomas
